FCE
GHDX

Fiera Capital (Europe)’s Genomic Health, Inc. GHDX Stock Holding History

Fiera Capital (Europe)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,035
Closed -$287 – 56
2014
Q4 		$287 Buy
3,035
+1,655
+120% +$53.9K 0.21% 27
2014
Q3 		$39K Sell
1,380
-106
-7% -$2.96K 0.03% 55
2014
Q2 		$41K Buy
+1,486
New +$39.6K 0.03% 54

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fiera Capital (Europe)'s GHDX Position: Q1 2015 in Review

Fiera Capital (Europe) sold out of Genomic Health, Inc. (GHDX) in Q1 2015, closing a stake of 3,035 shares — an estimated $287 sold.

Fiera Capital (Europe) first reported a position in GHDX in Q2 2014 and held it in 3 quarters. The position peaked at $41K in Q2 2014. 112 funds tracked by Wall St. Rank hold GHDX as of Q1 2015.

  • Fiera Capital (Europe) reported no remaining Genomic Health, Inc. position as of Q1 2015 after selling out during the quarter.
  • Fiera Capital (Europe) sold 3,035 Genomic Health, Inc. shares in Q1 2015, an estimated $287.
  • Fiera Capital (Europe) first reported a position in Genomic Health, Inc. in Q2 2014 and held it in 3 quarters.
  • Fiera Capital (Europe)'s Genomic Health, Inc. position peaked at $41K in Q2 2014.
  • 112 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2015.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2015, filed 12 May 2015.